Wed Sep 25 04:36:54 UTC 2024: ## HemaCare Stock Rises 0.6% in Mid-Day Trading
**September 25th, 2024** – HemaCare Co. (OTCMKTS:HEMA) saw its stock price rise by 0.6% during midday trading on Tuesday, reaching a high of $25.31 before closing at $25.31. Trading volume was significantly lower than average, with only 5,400 shares changing hands compared to the typical 39,950.
HemaCare Corporation is a leading provider of human-derived primary blood cells and tissues for the biomedical research community. The company specializes in the collection, isolation, and testing of these materials for research protocols and cellular therapy, supporting clinical trials and commercialization efforts.
While the stock experienced a modest gain today, it has been relatively stable recently, with its 50-day and 200-day moving averages both standing at $25.31.
To receive daily updates on HemaCare and related companies, including news and analyst ratings, sign up for MarketBeat.com’s free email newsletter.
First Piper 